Fact CheckerSign in

NCT07223320Active, not recruiting

HABIT-ILE + FST in Children With SMA

Feasibility and Preliminary Effectiveness of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + Functional Strength Training (FST) in Children With Spinal Muscular Atrophy (SMA): a Pilot Study

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

This single-arm pilot study will assess the feasibility and preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend one 6-hour HABIT-ILE + FST session each weekend (Saturday or Sunday) for 15 weeks, for a total of 90 hours of training. Feasibility will be evaluated through questionnaires, and effectiveness through standardized motor function assessments.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
5 (estimated)
First submitted
25 Sept 2025
Start date
1 Oct 2025
Primary completion date
31 Dec 2026
Lead sponsor
Teachers College, Columbia University
NCT number
NCT07223320

What you commit to

  • Study type: Interventional
  • Planned participants: 5
  • From 1 Oct 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Orthopedic surgery within the last year (confound)
  • Participation in a clinical trial of an investigational therapy

Other

  • Initiation of any new pharmaceutical treatment during the study period

Who the study is looking for

  • Diagnosis of SMA
  • Able to participate in all pre and post intervention assessments
  • Able to understand and speak English
  • Able to understand directions (no significant cognitive delay or serious behavioral issues that would limit participation)
  • Receiving a stable dose of disease-modifying therapies for at least 6 months prior to enrollment.

Age in the registry: 5 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Center for Cerebral Palsy Research, Teachers College, Columbia University
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.